Cognitive and brain structural changes in a lung cancer population

Journal of Thoracic Oncology

Volumn 10, Issue 1, 2015, Pages 38-45

  Simó, Marta ^a   Root, James C ^b   Vaquero, Lucía ^a   Ripollés, Pablo ^a   Jové, Josep ^c   Ahles, Tim ^b   Navarro, Arturo ^a   Cardenal, Felipe ^a   Bruna, Jordi ^a   Rodríguez Fornells, Antoni ^a,d,e  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Chemotherapy; Cognitive impairment; Diffusion tensor imaging; Lung cancer; Neuroimaging; Voxel based morphometry

Indexed keywords

ADULT; AMNESIA; ANTERIOR CINGULATE; ARTICLE; BRAIN; BRAIN MAPPING; BRAIN STRUCTURE; CANCER PATIENT; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; LUNG CANCER; MALE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGY; NON SMALL CELL LUNG CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAHIPPOCAMPAL GYRUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMALL CELL LUNG CANCER; VERBAL MEMORY; VOXEL BASED MORPHOMETRY; WHITE MATTER; COGNITION DISORDERS; LUNG TUMOR; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PROCEDURES; PSYCHOLOGY;

BRAIN; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES;

EID: 84926420820     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000345     Document Type: Article

References (45)

1. Jim HS, Phillips KM, Chait S, et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol 2012;30:3578-3587.
2. Ahles TA, Saykin AJ, Furstenberg CT, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 2002;20:485-493.
3. Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 2007;7:192-201.
4. Simó M, Rifà-Ros X, Rodriguez-Fornells A, Bruna J. Chemobrain: a systematic review of structural and functional neuroimaging studies. Neurosci Biobehav Rev 2013;37:1311-1321.
5. Inagaki M, Yoshikawa E, Matsuoka Y, et al. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 2007;109:146-156.
6. McDonald BC, Conroy SK, Ahles TA, West JD, Saykin AJ. Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat 2010;123:819-828.
7. Deprez S, Amant F, Yigit R, et al. Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp 2011;32:480-493.
8. Deprez S, Amant F, Smeets A, et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol 2012;30:274-281.
9. McDonald BC, Conroy SK, Smith DJ, West JD, Saykin AJ. Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain Behav Immun 2013;30 (Suppl):117-125.
10. de Ruiter MB, Reneman L, Boogerd W, et al. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp 2011;32:1206-1219.
11. de Ruiter MB, Reneman L, Boogerd W, et al. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp 2012;33:2971-2983.
12. Koppelmans V, de Ruiter MB, van der Lijn F, et al. Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat 2012;132:1099-1106.
13. Conroy SK, McDonald BC, Smith DJ, et al. Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast Cancer Res Treat 2013;137:493-502.
14. Scherling C, Collins B, Mackenzie J, et al. Structural brain differences in breast cancer patients compared to matched controls prior to chemotherapy. Int J Biol 2012;4:23.
15. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 2004;100:2292-2299.
16. Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D. The effects of adjuvant chemotherapy on cognition in women with breast cancer - preliminary results of an observational longitudinal study. Breast 2005;14:142-150.
17. Komaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1995;33:179-182.
18. Grosshans DR, Meyers CA, Allen PK, et al. Neurocognitive function in patients with small cell lung cancer: effect of prophylactic cranial irradiation. Cancer 2008;112:589-595.
19. Welzel T, Niethammer A, Mende U, et al. Diffusion tensor imaging screening of radiation-induced changes in the white matter after prophylactic cranial irradiation of patients with small cell lung cancer: first results of a prospective study. AJNR Am J Neuroradiol 2008;29:379-383.
20. Whitney KA, Lysaker PH, Steiner AR, Hook JN, Estes DD, Hanna NH. Is "chemobrain" a transient state? A prospective pilot study among persons with non-small cell lung cancer. J Support Oncol 2008;6:313-321.
21. Kaasa S, Olsnes BT, Thorud E, Høst H. Reduced short-term neuropsychological performance in patients with nonsmall-cell lung cancer treated with cisplatin and etoposide. Antibiot Chemother (1971) 1988;41:226-231.
22. Kaasa S, Olsnes BT, Mastekaasa A. Neuropsychological evaluation of patients with inoperable non-small cell lung cancer treated with combination chemotherapy or radiotherapy. Acta Oncol 1988;27:241-246.
23. Arriagada R, Le Chevalier T, Borie F, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 1995;87:183-190.
24. Gregor A, Drings P, Burghouts J, et al. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European organization for research and treatment of cancer lung cancer cooperative group study. J Clin Oncol 1997;15:2840-2849.
25. Mattis S. Dementia rating scale: professinal manual. Odessa, FL: Psychological Assessment Resources; 1988.
26. Correa DD, Root JC, Baser R, et al. A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients. Brain Imaging Behav 2013;7:478-490.
27. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage 2000;11(6 Pt 1):805-821.
28. Ashburner J, Friston KJ. Unified segmentation. Neuroimage 2005;26:839-851.
29. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007;38:95-113.
30. Ripollés P, Marco-Pallarés J, de Diego-Balaguer R, et al. Analysis of automated methods for spatial normalization of lesioned brains. Neuroimage 2012;60:1296-1306.
31. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23 (Suppl 1):208-219.
32. Leemans A, Jones DK. The B-matrix must be rotated when correcting for subject motion in DTI data. Magn Reson Med 2009;61:1336-1349.
33. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143-155.
34. Andersson JLR, Jenkinson M, Smith S. FMRIB Technical Report TR07JA1. 2007; available from http://www.fmrib.ox.ac.uk/analysis/techrep/tr07ja1/tr07ja1.pdf. Accessed September 2014.
35. Andersson JLR, Jenkinson M, Smith S. FMRIB Technical Report TR07JA2. 2007; available from http://www.fmrib.ox.ac.uk/analysis/techrep/tr07ja2/tr07ja2.pdf. Accessed September 2014.
36. Alexander AL, Lee JE, Lazar M, Field AS. Diffusion tensor imaging of the brain. Neurotherapeutics 2007;4:316-329.
37. Acosta-Cabronero J, Alley S, Williams GB, Pengas G, Nestor PJ. Diffusion tensor metrics as biomarkers in Alzheimer's disease. PLoS One 2012;7:e49072.
38. Eichenbaum H, Yonelinas AP, Ranganath C. The medial temporal lobe and recognition memory. Annu Rev Neurosci 2007;30:123-152.
39. Allman JM, Hakeem A, Erwin JM, Nimchinsky E, Hof P. The anterior cingulate cortex. The evolution of an interface between emotion and cognition. Ann N Y Acad Sci 2001;935:107-117.
40. Catani M, Jones DK, Donato R, Ffytche DH. Occipito-temporal connections in the human brain. Brain 2003;126(Pt 9):2093-2107.
41. Catani M, Thiebaut de Schotten M. A diffusion tensor imaging tractography atlas for virtual in vivo dissections. Cortex 2008;44:1105-1132.
42. Thiebaut de Schotten M, Dell'Acqua F, Forkel SJ, et al. A lateralized brain network for visuospatial attention. Nature neuroscience 2011;14:1245-1246.
43. Bernocchi G, Bottone MG, Piccolini VM, et al. Developing central nervous system and vulnerability to platinum compounds. Chemother Res Pract 2011;2011:315418.
44. Debette S, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011;77:461-468.
45. Ahles TA, Root JC, Ryan EL. Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol 2012;30:3675-3686.